Biotech · Private company
Istari Oncology, Inc.
Track this companyFree. Adds Istari Oncology, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials111 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- 5% DDMPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Anti-PD-1 Checkpoint InhibitorPhase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- lerapolturevPhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- lerapolturevPhase 2 · Malignant GliomaClinicalTrials.gov · fetched Nov 12, 2026
- LerapolturevPhase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- LerapolturevPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- LomustinePhase 2 · Malignant GliomaClinicalTrials.gov · fetched Nov 12, 2026
- pembrolizumabPhase 2 · GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- Polio/Rhinovirus Recombinant (PVSRIPO)Phase 1 · Malignant GliomaClinicalTrials.gov · fetched Nov 12, 2026
- PVSRIPOPhase 1 · Invasive Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- PVSRIPOPhase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)Phase 1 · GBMClinicalTrials.gov · fetched Nov 12, 2026
- PVSRIPOGlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Lerapolturev (PVSRIPO) in GBMPHASE2 · RECRUITING · started Jul 15, 2024ClinicalTrials.gov NCT06177964 · fetched Nov 12, 2026
- LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint InhibitorsPHASE1_PHASE2 · TERMINATED · started Aug 1, 2021ClinicalTrials.gov NCT04690699 · fetched Nov 12, 2026
- LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory MelanomaPHASE2 · COMPLETED · started Nov 17, 2020ClinicalTrials.gov NCT04577807 · fetched Nov 12, 2026
- LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent GlioblastomaPHASE2 · COMPLETED · started Oct 21, 2020ClinicalTrials.gov NCT04479241 · fetched Nov 12, 2026
- D2C7-IT With Atezolizumab for Recurrent GliomasPHASE1 · COMPLETED · started Feb 25, 2020ClinicalTrials.gov NCT04160494 · fetched Nov 12, 2026
- Examining Bioactivity of PVSRIPO in Invasive Breast CancerEARLY_PHASE1 · COMPLETED · started Jun 30, 2019ClinicalTrials.gov NCT03564782 · fetched Nov 12, 2026
- PVSRIPO for Patients With Unresectable MelanomaPHASE1 · TERMINATED · started Nov 26, 2018ClinicalTrials.gov NCT03712358 · fetched Nov 12, 2026
- Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in ChildrenPHASE1 · COMPLETED · started Nov 7, 2017ClinicalTrials.gov NCT03043391 · fetched Nov 12, 2026
- Lerapolturev in Recurrent Malignant GliomaPHASE2 · COMPLETED · started Jun 1, 2017ClinicalTrials.gov NCT02986178 · fetched Nov 12, 2026
- PVSRIPO for Recurrent Glioblastoma (GBM)PHASE1 · COMPLETED · started Apr 25, 2012ClinicalTrials.gov NCT01491893 · fetched Nov 12, 2026
- EAP for the Treatment of Glioblastoma With PVSRIPONO_LONGER_AVAILABLEClinicalTrials.gov NCT04599647 · fetched Nov 12, 2026